Coya TherapeuticsCOYA
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 26 institutions reported holding Coya Therapeutics Inc. (COYA) in their 13F filings, unchanged from Q4 2024. 5 opened new positions and 5 sold out. The largest holders were Greenlight Capital (DME Capital Management) ($10.7M), AIGH Capital Management LLC ($7.7M) and Vanguard Group Inc. ($5.4M). 3 famous investors held it, including David Einhorn (0.5% of Greenlight Capital (DME Capital Management)'s portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Coya Therapeutics Inc.
- CUSIP
- 22407B108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.6M |
| Exits | 5 | $543K |
All 13F filers, Q4 2024 → Q1 2025: 346,025 shares bought and 128,014 shares sold, net +218,011 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Greenlight Capital (DME Capital Management) | 0.54% | No change | 1,646,440 | $10.7M |
| AIGH Capital Management LLC | 3.97% | Reduce -1.4% | 1,183,780 | $7.7M |
| Vanguard Group Inc. | 0.00% | No change | 840,471 | $5.4M |
| CM Management, LLC | 1.30% | Add +25.0% | 200,000 | $1.3M |
| Dauntless Investment Group, LLC | 4.00% | New | 167,378 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +3.5% | 155,829 | $1.0M |
| BlackRock, Inc. | 0.00% | Add +10.0% | 83,795 | $542K |
| Susquehanna International Group, LLP | 0.00% | Add +91.9% | 58,982 | $382K |
| State Street Corp. | 0.00% | No change | 48,100 | $311K |
| Prelude Capital Management, LLC | 0.02% | No change | 35,770 | $231K |
| UBS Group AG | 0.00% | Reduce -20.8% | 34,089 | $221K |
| Citadel Advisors | 0.00% | New | 33,944 | $220K |
| Northern Trust Corp. | 0.00% | Add +9.2% | 31,179 | $202K |
| GHP Investment Advisors, Inc. | 0.01% | No change | 26,171 | $169K |
| Jane Street Group, LLC | 0.00% | Add +101.7% | 26,137 | $169K |
| Royal Bank of Canada | 0.00% | Reduce -8.8% | 20,652 | $134K |
| Atom Investors LP | 0.02% | Add +38.2% | 19,725 | $128K |
| Prosperity Wealth Management, Inc. | 0.05% | New | 16,050 | $104K |
| Renaissance Technologies | 0.00% | New | 12,200 | $79K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 10,000 | $65K |
| Morgan Stanley | 0.00% | Add +140.7% | 6,740 | $44K |
| Osaic Holdings, Inc. | 0.00% | No change | 3,342 | $22K |
| SBI Securities Co., Ltd. | 0.00% | Add +19.7% | 911 | $6K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 500 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -94.6% | 285 | $2K |
| Bank of America Corp. | 0.00% | Add +5.2% | 121 | $783 |
"% of holder's portfolio" is COYA's weight in each manager's 13F, not the share of Coya Therapeutics Inc. the manager owns.